1-slide. Qualitative procedure uses guaiac paper slide test. On-slide Performance Monitor* enables function and stability of reagents to be tested each time slide is developed. Positive results appear as blue development on edge of fecal smear.
Each box has 50 patient screening kits, three 15mL bottles of Hemoccult developer. Non-invasive. Performance Monitor* area on each test offers built-in quality control. Low-cost screening alternative to frequent endoscopy. Used in colorectal cancer screening.
Dispense pack. Qualitative procedure uses guaiac paper slide test. On-slide Performance Monitor* enables function and stability of reagents to be tested each time slide is developed. Positive results appear as blue development on edge of fecal smear.
Hemoccult single slides are guaiac-based fecal occult blood tests (FOBT) used to detect abnormal occult bleeding associated with gastrointestinal disorders.
Dispensapak* Plus. For screening programs for colorectal cancer. Vivid blue reaction provides high level of color stability and intensity. Contains 100 SENSA single slides, two 15mL bottles of developer, and 100 applicator sticks.
Dispensapak* Plus. For screening programs for colorectal cancer. Vivid blue reaction provides high level of color stability and intensity. With two 15mL bottles of SENSA developer and 40 patient kits.
Rapid test for detecting hCG qualitatively, employing a solid-phase chromatographic immunoassay technology to selectively detect elevated levels of hCG in serum or urine. Detects hCG at 10 mIU/mL in serum and 20 mIU/mL in urine. Built-in positive and negative controls.
Rapid immunochromatographic assay for the qualitative detection of Group A Strep antigen directly from a throat swab specimen. Easy-to-use CLIA-waived dipstick format test. 98% accuracy.